Fulviglen 250Mg/5Ml Inj contains Fulvestrant, used to treat breast cancer in postmenopausal women. Additionally, Fulviglen 250Mg/5Ml Inj may be used in combination with palbociclib to treat women with a type of breast cancer called hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer that is locally advanced or has spread to other parts of the body (metastatic).

FAQs

How does Fulviglen 250Mg/5Ml Inj work?

Fulviglen 250Mg/5Ml Inj contains Fulvestrant which works by inhibiting some of the actions of estrogen (female sex hormone) and reducing the amount that is in the body. Thus, it helps in reducing breast cancer tumour growth.

Is Fulviglen 250Mg/5Ml Inj safe for patients with liver problems?

Fulviglen 250Mg/5Ml Inj is not recommended for patients with severe liver problems. Therefore, if you have any liver problems, inform your doctor before receiving Fulviglen 250Mg/5Ml Inj.

Does Fulviglen 250Mg/5Ml Inj cause weakness?

Fulviglen 250Mg/5Ml Inj may cause weakness or tiredness as a common side effect. However, if weakness persists or worsens, please consult your doctor.